Category: Research
BA.2.75.2 and BQ.1.1 approaching SARS-1 levels of escape
A new Twitter thread out today from Yunlong Cao gives further details about the variants BA.2.75 and BQ.1.1. More...
Preprint: Reevaluation of antibody-dependent enhancement for SARS-CoV-2 treatments
A new preprint looking at the evidence for antibody-dependent enhancement (ADE) is getting a LOT of attention online – we link to it below so that you can read it for yourself. More...
Preprint: Russian Khosta-2 bat virus resistant to SARS-CoV-2 vaccines
“We found that the spike from virus, Khosta-2, could infect cells similar to human pathogens using the same entry mechanisms, but was resistant to neutralization by serum from individuals who had been vaccinated for SARS-CoV-2.” More...
Japan: More than 800 infected with Covid after dance festival superspreader event
819 people were found to have been infected with coronavirus after a summer dance festival turned into a Covid superspreader event. More...
Research: All COVID-19 infections include a wide mix of SARS-CoV-2 virus variants
A fascinating peer reviewed research study that concludes that ALL Covid infections include multiple variants of the virus! More...
Long Covid: Impaired lung function for months after infection
Two different research articles out recently give graphic details of the lung damage that can be caused in both adults and children after a Covid infection. More...
Research: Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection
“Remdesivir treatment can increase intra-host genomic diversity and result in the emergence of novel major variant species harboring fixed mutations,”. More...
Research: Nasal saline irrigation reduces severity in high-risk COVID patients
SARS-CoV-2 positive participants initiating nasal irrigation were over 8 times less likely to be hospitalized than the national rate. More...
Lancet: Natural immunity associated with a 95% lower risk of SARS-CoV-2 infection
After the first 3 months, natural immunity was associated with a 95% lower risk of SARS-CoV-2 infection and an 87% lower risk of COVID-19 hospitalisation for up to 20 months. More...